Evidence map›Paper›PMID 16151791›Full record

ArticlePflugers Archiv : European journal of physiology2006

Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells.

Theresa J Berndt, Bernhard Bielesz, Theodore A Craig, Peter J Tebben, Desa Bacic, Carsten A Wagner, Stephen O'Brien, Susan Schiavi, Jurg Biber, Heini Murer and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. The Intricacies of Renal Phosphate Reabsorption-An Overview.International journal of molecular sciences · 2024
    Review
  3. Review
  4. Phosphaturic mesenchymal tumors: what an endocrinologist should know.Journal of endocrinological investigation · 2018
    Review
  5. Acute Adaption to Oral or Intravenous Phosphate Requires Parathyroid Hormone.Journal of the American Society of Nephrology : JASN · 2017
    Article
  6. Tumor-Induced Osteomalacia.Translational endocrinology & metabolism · 2015
    Article
  7. Article
  8. Phosphatonins: new hormones involved in numerous inherited bone disorders.Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases · 2011
    Article
  9. Article
  10. Article
  11. Regulation of phosphate transport in proximal tubules.Pflugers Archiv : European journal of physiology · 2009
    Review
  12. Article
  13. Review
  14. Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis.Laboratory investigation; a journal of technical methods and pathology · 2009
    Review
  15. Review
  16. Biological activity of FGF-23 fragments.Pflugers Archiv : European journal of physiology · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Theresa J BerndtDivision of Nephrology and Hypertension, Departments of Medicine and Biochemistry and Molecular Biology, Mayo Clinic Rochester, Mayo College of Medicine, MN, 55905, USA.
Bernhard Bielesz
Theodore A Craig
Peter J Tebben
Desa Bacic
Carsten A Wagner
Stephen O'Brien
Susan Schiavi
Jurg Biber
Heini Murer
Rajiv Kumar
Mayo Clinic · USSwiss Integrative Center for Human Health · CHUniversity of Zurich · CHIo Therapeutics (United States) · US

Funding

Biology of a Novel Phosphaturic Protein - sFRP-4R01DK065830 · NIDDK · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV · 2004 to 2007
$1.2M
NIDDK NIH HHS DK 65830NIDDK NIH HHS R01 DK065830
6 · The paper itself

Abstract

The phosphatonin, secreted frizzled-related protein-4 (sFRP-4), induces phosphaturia and inhibits 25-hydroxyvitamin D 1alpha-hydroxylase activity normally induced in response to hypophosphatemia. To determine the mechanism by which sFRP-4 alters renal phosphate (P(i)) transport, we examined the effect of sFRP-4 on renal brush border membrane (BBMV) Na(+)-dependent P(i) uptake, and the abundance and localization of the major Na(+)-P(i)-IIa co-transporter in proximal tubules and opossum kidney (OK) cells. Infusion of sFRP-4 increased renal fractional excretion of P(i) and decreased renal beta-catenin concentrations. The increase in renal P(i) excretion with sFRP-4 infusion was associated with a 21.9 +/- 3.4% decrease in BBMV Na(+)-dependent P(i) uptake (P < 0.001) compared with a 39.5 +/- 2.1% inhibition of Na(+)-dependent P(i) transport in renal BBMV induced by PTH (P < 0.001). sFRP-4 infusion was associated with a 30.7 +/- 4.8% decrease in Na(+)-P(i)-IIa co-transporter protein abundance (P < 0.01) assessed by immunoblotting methods compared to a 45.4 +/- 8.8% decrease induced by PTH (P < 0.001). In OK cells, sFRP-4 reduced surface expression of a heterologous Na(+)-P(i)-IIa co-transporter. We conclude that sFRP-4 increases renal P(i) excretion by reducing Na(+)-P(i)-IIa transporter abundance in the brush border of the proximal tubule through enhanced internalization of the protein.

Indexed as

AnimalsCells, CulturedHumansKidney Tubules, ProximalMaleOpossumsProto-Oncogene ProteinsRatsRats, Sprague-DawleySecreted Frizzled-Related ProteinsSodium-Phosphate Cotransporter Proteins, Type IIaProto-Oncogene ProteinsSecreted Frizzled-Related ProteinsSFRP4 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIa

Identifiers

PMID16151791
OpenAlexW2020310544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.